Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat - the MIGA-FAB Study

NCT04602364 is registered in ClinicalTrials.gov with Amicus Therapeutics France SAS as lead sponsor.

NCT NCT04602364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat - the MIGA-FAB Study
Lead sponsor
Amicus Therapeutics France SAS
Phase
Observational
Overall status
Completed
Start date
October 15, 2020
Completion date
June 30, 2023
Enrollment
48 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

fabry disease